New drug safety check for rare genetic disorder
NCT ID NCT07219485
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 29 times
Summary
This study checks the safety of a drug called pitolisant in 150 people with Prader-Willi syndrome who have already taken it in a previous study. Researchers will track any side effects that happen during treatment and for 30 days after the last dose. The goal is to make sure the drug is safe for long-term use in this condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRADER-WILLI SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Science 37
Morrisville, North Carolina, 27560, United States
Conditions
Explore the condition pages connected to this study.